Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical ...
Wegovy, is primarily an antidiabetic medication used to treat Type 2 diabetes. People receiving weight-loss drug Wegrovy ...
People taking the weight loss drug Zepbound experienced dramatically greater weight loss than competitor Wegovy in the first head-to-head trial.
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...
The Biden administration Tuesday announced plans to provide coverage for a class of costly anti-obesity medications including Wegovy and Zepbound for those enrolled in Medicare and Medicaid.